Comparison of lobectomy vs total thyroidectomy for medullary thyroid carcinoma: a SEER analysis with Chinese cohort validation
The Oncologist · 2025
DOI: 10.1093/oncolo/oyaf250 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Oncologist, 2025. Verfasst von Jing Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroidectomy, Carcinoma, Neuroendocrine. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
This study aimed to clarify whether lobectomy provides survival benefits for patients with early-stage medullary thyroid carcinoma (MTC). Design, Setting, and Participants Patients with tumor size less than 4 cm, excluding those with lateral neck involvement, bilateral foci, extrathyroidal extension, or distant metastases, were enrolled from the Surveillance, Epidemiology, and End Results (SEER) database and Zhejiang Cancer Hospital in China. Propensity score matching (PSM), Kaplan-Meier analysis, and Cox regression analyses were used to evaluate treatment outcomes and identify risk factors.
Results
Among 1009 patients in the SEER database, TT was associated with multifocality (P < .001) and local nodal metastasis (P < .001). After PSM, 73 pairs were matched. In the Chinese cohort from Zhejiang Cancer Hospital, TT was correlated with larger tumor (P < .001), higher calcitonin peak-to-basal ratio (P = .002), and T2 stage (P = .025), with 38 matched pairs after PSM. Cox regression analyses showed that the extent of thyroid resection was not an independent prognostic factor for overall survival (SEER: OS P = .607) or progression-free survival (Chinese cohort: PFS P = .411). Kaplan-Meier analysis revealed no significant survival differences between the TT and lobectomy groups (SEER: OS P = .43; Chinese cohort: PFS P = .21). Additionally, the TT group had more frequent adverse events (transient hypocalcemia: P < .001, transient vocal cord paralysis: P < .025), longer hospital stays (P = .011), and higher costs (P = .001) than the lobectomy group.
Conclusions
For patients with early-stage MTC, lobectomy may be an optimal alternative option that does not impair prognosis and confers a low risk of adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China.
- Department of Medical Records and Statistics, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China.
- Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China.
ORCID-Profile: Jing Yang, Ling-Yan Zhou
Zitieren
APA
Yang, J., Wang, J. Y., Lu, Y. D., Wang, K. J., & Zhou, L. Y. (2025). Comparison of lobectomy vs total thyroidectomy for medullary thyroid carcinoma: a SEER analysis with Chinese cohort validation. The Oncologist. https://doi.org/10.1093/oncolo/oyaf250
Vancouver
Yang J, Wang JY, Lu YD, Wang KJ, Zhou LY. Comparison of lobectomy vs total thyroidectomy for medullary thyroid carcinoma: a SEER analysis with Chinese cohort validation. The Oncologist. 2025. doi:10.1093/oncolo/oyaf250
BibTeX
@article{Yang2025,
author = {Yang, Jing and Wang, Jin-Yu and Lu, Yi-Dan and Wang, Ke-Jing and Zhou, Ling-Yan},
title = {Comparison of lobectomy vs total thyroidectomy for medullary thyroid carcinoma: a SEER analysis with Chinese cohort validation},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyaf250}
}
EUVIMED